Current Social and Economic Issues
GA 332b — 25 March 1924, Dornach
The End of Futurum AG
From the minutes of the extraordinary general meeting of the International Laboratories and Clinical-Therapeutic Institute Arlesheim AG.
The meeting is opened by Dr. Ita Wegman. She proposes that Dr. Steiner be elected as president for the day. He provides information about the reasons for the new write-off of the “Futurum” assets in accordance with the meeting of March 24, 1924 [see page 425] and proposes: 1. To approve a contract between the Internationale Laboratorien und Klinisch-Therapeutisches Institut Arlesheim A.G. and 'Futurum A.G. in Lig.', by which the takeover of 'Futurum' can be undertaken for 450,000 francs. 2. To this end, the share capital of the International Laboratories and Clinical-Therapeutic Institute Arlesheim A.G. is to be increased from 500,000 francs to 950,000 francs. Both proposals are unanimously adopted.
Rudolf Steiner: As you know, we are striving to make a clear distinction between the spiritual and commercial interests of our members. This is particularly necessary for the Clinical Therapeutic Institute, which is to be separated from the International Laboratories by uniting with the Goetheanum Association. Furthermore, an experimental laboratory is to be affiliated to it, while the actual laboratories are to continue to be operated as a commercial enterprise under the title “Internationale Laboratorien Arlesheim A. G. Arlesheim” with a share capital of 950,000 francs. This independence will make it possible to put the business on a healthy and profitable footing.
Dr. Wegman and Dr. Steiner will remain closely connected with the clinic, which is now to become an integral part of the Goetheanum, especially with regard to the production of the remedies. In a meeting preceding today's general assembly, the board of directors decided to submit the following proposal for approval:
The International Laboratories and the Clinical-Therapeutic Institute Arlesheim A.G. in Arlesheim sell the Clinical-Therapeutic Institute to the Verein des Goetheanum. The exact purchase price will be determined by the Board of Directors after the annual balance sheet as of December 31, 1923, has been prepared. The company name is changed to “Internationale Laboratorien Arlesheim A.G. in Arlesheim”.
This proposal is unanimously approved. Since these resolutions also require a reorganization of the Board of Directors, Mrs. G. Ricardo, who is staying in America for an extended period, is recalled as a member of the Board of Directors, and Dr. Ita Wegman resigns. Mr. Emanuel Joseph van Leer and Mr. Edgar Dürler are newly elected to the remaining member of the Board of Directors, Mr. Geering-Christ. The auditors must be replaced due to the resignation of the previous members, Ms. M. Viehoff and Mr. Karl Day. The following are proposed as replacements: Dr. Rudolf Steiner in Dornach, Dr. Ita Wegman in Arlesheim.
The chairman of the meeting (Dr. Steiner) emphasized that this would establish the necessary contact between the Goetheanum Association, which is purely spiritual, and the international laboratories, which are commercial. This solution guarantees the necessary cooperation.
The vote is unanimous in favor of the proposed candidates. At the end of the meeting, the chairman notes that the resolutions passed today annul those of the Annual General Meeting of April 5, 1923.